Host: Fouad T. Chebib, MD Guest: Pranav S. Garimella, MD This Expert Exchange webcast is designed to help improve clinicians ability to apply pharmacologic and non-pharmacologic strategies in the management of patients with ADPKD.

Host: Jillian Ziemanski, OD, PhD, FAAO Guest: Cynthia Matossian, MD, FACS How can more advanced measures improve meibomian gland function to relieve dry eye symptoms and improve refraction? Listen as Dr. Cynthia Matossian and Dr. Jillian Zi

Host: Thomas F. Patterson, MD, FACP, FIDSA Guest: George Thompson III, MD, FIDSA The changing epidemiology of invasive fungal infections, ongoing antifungal resistance, drug-drug interactions, and few oral agents leave patients with limited viable

Host: John J. Russell, MD Guest: Robert F. Kushner, MD Obesity affects 600 million people globally and over one third of the American population. Along with associated comorbidities, including cardiovascular disease, stroke, diabetes, and ca

Host: Andrew H. Lipsky, MD Guest: Jacob D. Soumerai, MD Guest: Catherine C. Coombs, MD The emerging treatment landscape for chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) has resulted in improved outcomes for patients. Ho

Host: Peter G. Pappas, MD, FACP Guest: Thomas F. Patterson, MD, FACP, FIDSA Despite advances in diagnosis and treatment, as well as the dissemination of clinical practice guidelines, both the threat and burden of invasive fungal infections are incr

Host: Saad Z. Usmani, MD, MBA, FACP Guest: Sikander Ailawadhi, MD Guest: Amrita Krishnan, MD Given the complexity of care for patients with multiple myeloma (MM) and the mounting clinical trial data, it is crucial to stay abreast of investigation

Host: Sara W. Koblitz Guest: Michael J. Thorpy, MD While most clinicians are aware of a drug being either approved or not approved by the FDA, many are not familiar with the term tentative approval. Leading experts, attorney Sara Koblitz, JD,

Host: Martin Pollak, MD Guest: Susanne Nicholas, MD, MPH, PhD End-stage kidney disease (ESKD) is at least 3x higher among African Americans compared to Americans of European descent. Carriers of APOL1 variants with chronic kidney disease (CKD) are

Host: Warner K. Huh, MD Guest: Leigh Anne Cantrell, MD, MSPH Guest: Mark H. Stoler, MD Experts discuss the ACS and ASCCP CCV screening guidelines and review the benefits of primary screening and the latest data driven testing options. Is Pap cyto